237 related articles for article (PubMed ID: 34972756)
21. Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
Kim HL; Mayerson E; Lara PN; Messing E; Tangen C; Shuch BM; Vaishampayan U
Eur Urol Focus; 2019 Nov; 5(6):927-929. PubMed ID: 31103605
[TBL] [Abstract][Full Text] [Related]
22. Mucinous tubular and spindle cell carcinoma of the kidney associated with tuberculosis.
Makni SK; Chaari C; Ellouze S; Ayadi L; Charfi S; Abbes K; Slimen MH; Mhiri MN; Boudaoura TS
Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):335-8. PubMed ID: 21422638
[TBL] [Abstract][Full Text] [Related]
23. Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma.
Tachibana H; Kondo T; Ishihara H; Fukuda H; Yoshida K; Takagi T; Izuka J; Kobayashi H; Tanabe K
Jpn J Clin Oncol; 2021 Apr; 51(4):646-653. PubMed ID: 33212488
[TBL] [Abstract][Full Text] [Related]
24. Long-time Survival of a Renal Transplant Recipient With Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report.
Kobari Y; Yoshida K; Minoda R; Fukuda H; Hata K; Unagami K; Iizuka J; Ishida H; Nagashima Y; Takagi T
In Vivo; 2023; 37(3):1394-1398. PubMed ID: 37103106
[TBL] [Abstract][Full Text] [Related]
25. A case of high-grade mucinous tubular and spindle cell carcinoma.
Miura K; Adachi Y; Shirahase T; Nagashima Y; Suemune K; Sakaida N; Nakano Y; Sakai Y; Shimizu S; Ikehara S
J Surg Case Rep; 2020 Feb; 2020(2):rjaa014. PubMed ID: 32104563
[TBL] [Abstract][Full Text] [Related]
26. [LAPAROSCOPIC LYMPHADENECTOMY FOR POSTOPERATIVE LYMPH-NODE METASTASIS OF RENAL MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA: A CASE REPORT].
Mikami H; Endo Y; Yanagi M; Nemoto K; Hamasaki T; Kimura G; Suzuki Y; Kondo Y
Nihon Hinyokika Gakkai Zasshi; 2017; 108(1):30-34. PubMed ID: 29367506
[TBL] [Abstract][Full Text] [Related]
27. Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes.
Ged Y; Chen YB; Knezevic A; Donoghue MTA; Carlo MI; Lee CH; Feldman DR; Patil S; Hakimi AA; Russo P; Voss MH; Motzer RJ
Clin Genitourin Cancer; 2019 Aug; 17(4):268-274.e1. PubMed ID: 31151928
[TBL] [Abstract][Full Text] [Related]
28. Temporal trends of adverse events and costs of nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma.
Geynisman DM; Du EX; Yang X; Sendhil SR; Tejo VD; Betts KA; Huo S
Future Oncol; 2022 Mar; 18(10):1219-1234. PubMed ID: 34939424
[TBL] [Abstract][Full Text] [Related]
29. [A case of mucinous tubular and spindle cell carcinoma of the kidney].
Takagi K; Yamada Y; Uno M; Komeda H; Fujimoto Y
Hinyokika Kiyo; 2010 Mar; 56(3):159-62. PubMed ID: 20372044
[TBL] [Abstract][Full Text] [Related]
30. [A Case of Metastatic Renal Cell Carcinoma with Arthritis and Colitis Due to Immune-Related Adverse Events During Ipilimumab-Nivolumab Combination Therapy].
Toyoshima M; Ikarashi D; Tsuboi H; Moriwaka M; Tamada S; Matsuura T; Maekawa S; Kato R; Kanehira M; Takata R; Sugimura J; Obara W
Hinyokika Kiyo; 2023 Aug; 69(8):227-232. PubMed ID: 37667600
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors in patients with renal cell carcinoma.
Kikuchi H; Osawa T; Matsumoto R; Abe T; Maruyama S; Harabayashi T; Miyata H; Kashiwagi A; Ikeshiro S; Sazawa A; Fukui R; Morita K; Takeuchi I; Hori K; Yamashita N; Minami K; Mochizuki T; Murai S; Shinohara N
Urol Oncol; 2022 Jan; 40(1):13.e19-13.e27. PubMed ID: 34716079
[TBL] [Abstract][Full Text] [Related]
32. A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell Carcinoma.
Kato R; Kojima T; Sazuka T; Yamamoto H; Fukuda S; Yamana K; Sugino Y; Hamamoto S; Nakaigawa N; Kabu K; Murakami H; Obara W
Anticancer Res; 2021 Dec; 41(12):6199-6209. PubMed ID: 34848474
[TBL] [Abstract][Full Text] [Related]
33. Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma.
Kobari Y; Yoshida K; Iizuka J; Kondo T; Ishida H; Tanabe K; Takagi T
In Vivo; 2021; 35(6):3585-3589. PubMed ID: 34697199
[TBL] [Abstract][Full Text] [Related]
34. Mucinous tubular and spindle cell carcinoma with aggressive histomorphology--a sarcomatoid variant.
Pillay N; Ramdial PK; Cooper K; Batuule D
Hum Pathol; 2008 Jun; 39(6):966-9. PubMed ID: 18400251
[TBL] [Abstract][Full Text] [Related]
35. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid transformation.
Arafah M; Zaidi SN
Saudi J Kidney Dis Transpl; 2013 May; 24(3):557-60. PubMed ID: 23640631
[TBL] [Abstract][Full Text] [Related]
36. Mucinous tubular and spindle cell carcinoma of kidney: A case report of an unusual tumor.
Chander B; Bharti R; Preet K; Deb P
J Cancer Res Ther; 2015; 11(3):659. PubMed ID: 26458668
[TBL] [Abstract][Full Text] [Related]
37. Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib.
Iacovelli R; Ciccarese C; Maruzzo M; Atzori F; Galli L; Scagliarini S; Massari F; Verzoni E; Cannella A; Maratta MG; Caserta C; Bimbatti D; Deppieri FM; Dessi M; Paolieri F; Riccardi F; Bracarda S; De Giorgi U; Basso U; Tortora G; Procopio G
Clin Genitourin Cancer; 2022 Oct; 20(5):498.e1-498.e9. PubMed ID: 35768316
[TBL] [Abstract][Full Text] [Related]
38. A Case of Metastatic Fumarate Hydratase-Deficient-like Renal Cell Carcinoma Successfully Managed by Ipilimumab plus Nivolumab.
Sekito T; Takamoto A; Kobayashi Y; Mitsui M; Watari S; Kubota R; Sadahira T; Iwata T; Nishimura S; Edamura K; Sako T; Araki M; Watanabe M; Watanabe T; Shibata R; Ennishi D; Nasu Y
Acta Med Okayama; 2021 Jun; 75(3):397-402. PubMed ID: 34176946
[TBL] [Abstract][Full Text] [Related]
39. Mucin-poor and aggressive mucinous tubular and spindle cell carcinoma of the kidney: Two case reports.
Uchida S; Suzuki K; Uno M; Nozaki F; Li CP; Abe E; Yamauchi T; Horiuchi S; Kamo M; Hattori K; Nagashima Y
Mol Clin Oncol; 2017 Nov; 7(5):777-782. PubMed ID: 29075488
[TBL] [Abstract][Full Text] [Related]
40. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes.
Kenney PA; Vikram R; Prasad SR; Tamboli P; Matin SF; Wood CG; Karam JA
BJU Int; 2015 Jul; 116(1):85-92. PubMed ID: 25395040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
